You are here

P&T News

March 24

The human anti-PD-L1 antibody is the first therapy for this rare skin cancer
CTSA program paves way for nationwide single IRB model
MRIs more dependable than patient preference to determine best approach
John Hopkins experts call for early-detection strategies
Scientists working to develop the potential of nuclear receptors

March 23

Health care job growth is down 23% compared with last year
Senators complain about drug makers’ abuses
Ocrevus and Dupixent set to make a splash
Retrospective data must be confirmed in clinical trials

March 22

Two dozen Republicans oppose the plan
Former FDA heads say imported medications are too risky
Monoamine oxidase B inhibitor approved as add-on to levodopa
Treatment debuted at annual cost of $94,500

March 21

“Per-capita caps” plan comes under fire
Days may be numbered for controversial payment initiatives
Procedure should be avoided in small heart vessels
FDA approval decision expected in April
“Blocking molecule” targets links that hold bacteria together